FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and is used for treating individuals suffering from hormonal diseases.
EFFECT: there are described methods and a device for octreotide delivery to the patients involving the implantation of a controlled release composition for octreotide delivery; the composition avoids the need of pre-implantation hydration and optionally contains a parting agent.
10 cl, 11 ex, 7 tbl, 17 dwg
Authors
Dates
2014-06-10—Published
2009-07-10—Filed